Institution identification

PURI

https://redirect.ema.europa.eu/resource/47342

Institution ID

47342

Institution full name and acronym

Department of medicine Solna/Clinical epidemiology division, Centre for Pharmacoepidemiology (CPE), Karolinska Institutet

Institution countries

Sweden

Type of institution

Educational Institution
Hospital/Clinic/Other health care facility
Laboratory/Research/Testing facility

Institution website

ENCePP partner

Yes
Institution description
CPE is lead by acting director Caroline Öberg. CPE's steering group includes representatives from academia,government agencies,regulatory authorities,pharmaceutical industry and Stockholm's county council. CPE strives to meet the demands from both national and international stakeholders in society and industry concerning data on drug safety,drug utilization,rational drug use and pharmacogenetics. Sweden has a unique opportunity to meet these demands by using national healthcare databases,bio banks,as well as having high levels of expertise in the fields of epidemiologically,pharmacology and other areas. CPE is mainly focusing on drug safety evaluation using data from the Swedish national registers. We have identified five research areas where we in particular can provide expert competence: •Chronic diseases and biologics •CNS and drugs •Drugs during pregnancy and infancy •Cardiovascular diseases and drugs •Cancer and drugs
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact